• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Connect with Us
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

European Alliance of Associations for Rheumatology (EULAR) 2021

June 2 - 5, 2021

  1. Anifrolumab
  2. AZD9567
  3. General

Html

Relationship of Anifrolumab PK with Efficacy and Safety in Patients with SLE

Html

Characterization of PK/PD of Anifrolumab in Patients with Moderate to Severe SLE

Html

Novel Stringent Outcomes Measures Applied to the Phase 2 and 3 Anifrolumab Trials

Html

Randomized, Controlled, Phase 2 Trial of Type 1 IFN Inhibitor Anifrolumab in Patients with Active Proliferative Lupus Nephritis 

Html

Anifrolumab Effects on Rash and Arthritis in Patients with SLE and Impact of Interferon Signal in Pooled Data from Phase 3 Trials

Html

Effects of Anifrolumab on Renal Disease in Patients with SLE

Html

Patient Reported Physical Health Compared to Clinician Recorded BILAG-2004 Muscoloskeletal System Scores - Discordance Between Patients with Clinicians 

Html

AZD9567 versus Prednisolone in Patients with Active Rheumatoid Arthritis: A Phase 2a, Randomized, Double-Blind, Parallel-Group Efficacy and Safety Study

Html

Short-term risk of osteoporosis in adults treated with corticosteroids: an observational study. 

Need Help?

Contact Us

Find an MSL

Chat with a Medical Affairs Associate

Send MIR

Submit a Medical Information Request

Disclaimer

Some content may have changed since publication. Some links may require registration/login to access the content. Any attached publications and/or any tables or figures derived from the publications are copyright-protected works. Med Co has obtained permission from the copyright owner to use this work on this site. You may not reproduce, prepare derivative works from, display or distribute this work unless you obtain the permission of the copyright owner, or as otherwise might be permitted by law.

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am a payer or formulary decision-maker
I am neither (take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2022 AstraZeneca. All rights reserved.

US-69609

Last Updated 11/22

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Privacy Notice

Legal Notice

Cookie Notice

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Pharma Logo

Privacy NoticeLegal NoticeCookie Notice